Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative splicing in disease and therapy.

Mariano A Garcia-Blanco1, Andrew P Baraniak, Erika L Lasda

  • 1Department of Molecular Genetics and Microbiology, Center for RNA Biology, Box 3053, Research Drive, Duke University Medical Center, Durham, North Carolina 27710, USA. garci001@mc.duke.edu

Nature Biotechnology
|May 4, 2004
PubMed
Summary

Alternative splicing generates protein diversity crucial for human health and disease. Modified oligonucleotides show promise for correcting aberrant splicing, offering a potential molecular therapy approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPR182 is a lipoprotein receptor for dietary fat absorption.

The Journal of clinical investigation·2026
Same author

Experimental validation of compound 3md, identified in silico, demonstrates antiviral effect on DENV2 by intervention in the replicative phase.

Virology·2026
Same author

Harnessing mRNA technology against <i>Fasciola hepatica</i>: Immunological insights from a fatty acid binding protein vaccine.

Frontiers in immunology·2025
Same author

Y-box binding proteins in immunity and RNA virus infection.

Microbiology and molecular biology reviews : MMBR·2025
Same author

Discovery of thiacyanine dyes as a new class of potent coronavirus inhibitors that suppress viral RNA synthesis.

The Journal of biological chemistry·2025
Same author

B cells shape naive CD8+ T cell programming.

The Journal of clinical investigation·2025

Area of Science:

  • Molecular biology
  • Genetics
  • Human physiology

Background:

  • Alternative splicing significantly contributes to human proteome diversity.
  • Dysregulation of alternative splicing is implicated in various diseases, including cystic fibrosis.
  • Aberrant splicing leads to abnormal protein production, impacting cellular function.

Purpose of the Study:

  • To highlight the significance of alternative splicing in human health and disease.
  • To discuss the potential of molecular therapies for correcting erroneous splicing.
  • To explore the therapeutic applications of modified oligonucleotides in splicing modulation.

Main Methods:

  • Review of recent experimental findings on alternative splicing.
  • Analysis of the role of cis-acting elements and trans-acting factors in splicing regulation.

Related Experiment Videos

  • Investigation of modified oligonucleotides as therapeutic agents.

    • Main Results:

    • Alternative splicing generates diverse protein isoforms, with implications for drug targets like cyclooxygenase 1 (COX-1).
    • Mutations affecting splicing machinery can cause diseases like cystic fibrosis.
    • Modified oligonucleotides demonstrate potential in modulating aberrant splicing events.

    Conclusions:

    • Alternative splicing is a critical process in human biology with significant disease relevance.
    • Targeting aberrant splicing through molecular therapies, such as oligonucleotide-based approaches, holds therapeutic promise.